Literature DB >> 26556528

Photodynamic Therapy with Blended Conducting Polymer/Fullerene Nanoparticle Photosensitizers.

Mona Doshi1, Andre J Gesquiere2.   

Abstract

In this article a method for the fabrication and reproducible in-vitro evaluation of conducting polymer nanoparticles blended with fullerene as the next generation photosensitizers for Photodynamic Therapy (PDT) is reported. The nanoparticles are formed by hydrophobic interaction of the semiconducting polymer MEH-PPV (poly[2-methoxy-5-(2-ethylhexyloxy)-1,4-phenylenevinylene]) with the fullerene PCBM (phenyl-C61-butyric acid methyl ester) in the presence of a non-compatible solvent. MEH-PPV has a high extinction coefficient that leads to high rates of triplet formation, and efficient charge and energy transfer to the fullerene PCBM. The latter processes enhance the efficiency of the PDT system through fullerene assisted triplet and radical formation, and ultrafast deactivation of MEH-PPV excited stated. The results reported here show that this nanoparticle PDT sensitizing system is highly effective and shows unexpected specificity to cancer cell lines.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26556528      PMCID: PMC4692674          DOI: 10.3791/53038

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  11 in total

1.  Photoinduced electron transfer from a conducting polymer to buckminsterfullerene.

Authors:  N S Sariciftci; L Smilowitz; A J Heeger; F Wudl
Journal:  Science       Date:  1992-11-27       Impact factor: 47.728

2.  Separately doped upconversion-C60 nanoplatform for NIR imaging-guided photodynamic therapy of cancer cells.

Authors:  Xiaomin Liu; Min Zheng; Xianggui Kong; Youlin Zhang; Qinghui Zeng; Zaicheng Sun; Wybren Jan Buma; Hong Zhang
Journal:  Chem Commun (Camb)       Date:  2013-03-12       Impact factor: 6.222

Review 3.  Cancer nanotechnology: opportunities and challenges.

Authors:  Mauro Ferrari
Journal:  Nat Rev Cancer       Date:  2005-03       Impact factor: 60.716

Review 4.  Photodynamic therapy for cancer.

Authors:  Dennis E J G J Dolmans; Dai Fukumura; Rakesh K Jain
Journal:  Nat Rev Cancer       Date:  2003-05       Impact factor: 60.716

Review 5.  Photodynamic therapy in oncology: mechanisms and clinical use.

Authors:  H I Pass
Journal:  J Natl Cancer Inst       Date:  1993-03-17       Impact factor: 13.506

6.  Water-dispersible fullerene aggregates as a targeted anticancer prodrug with both chemo- and photodynamic therapeutic actions.

Authors:  Jianquan Fan; Gang Fang; Fang Zeng; Xiaodan Wang; Shuizhu Wu
Journal:  Small       Date:  2012-11-01       Impact factor: 13.281

Review 7.  Photodynamic therapy.

Authors:  T J Dougherty; C J Gomer; B W Henderson; G Jori; D Kessel; M Korbelik; J Moan; Q Peng
Journal:  J Natl Cancer Inst       Date:  1998-06-17       Impact factor: 13.506

Review 8.  Toxicity of pristine versus functionalized fullerenes: mechanisms of cell damage and the role of oxidative stress.

Authors:  Andreja Trpkovic; Biljana Todorovic-Markovic; Vladimir Trajkovic
Journal:  Arch Toxicol       Date:  2012-05-05       Impact factor: 5.153

9.  Applications of functionalized fullerenes in tumor theranostics.

Authors:  Zhiyun Chen; Lijing Ma; Ying Liu; Chunying Chen
Journal:  Theranostics       Date:  2012-03-01       Impact factor: 11.556

10.  Photoinduced electron-transfer mechanisms for radical-enhanced photodynamic therapy mediated by water-soluble decacationic C₇₀ and C₈₄O₂ Fullerene Derivatives.

Authors:  Felipe F Sperandio; Sulbha K Sharma; Min Wang; Seaho Jeon; Ying-Ying Huang; Tianhong Dai; Suhasini Nayka; Suzana C O M de Sousa; Long Y Chiang; Michael R Hamblin
Journal:  Nanomedicine       Date:  2012-10-29       Impact factor: 5.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.